These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22416)

  • 1. Antiarrhythmic properties of 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a newly synthesized, potent beta-adrenoreceptor antagonist.
    Yabuuchi Y; Hashimoto K; Yamashita S; Uno T; Shintani S; Nakagiri N
    Clin Exp Pharmacol Physiol; 1977; 4(6):545-59. PubMed ID: 22416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic activity of dextro- and levo-isomers of 5-methyl-8-(2-hydroxy-3-t-butylamino-propoxy) coumarin hydrocholoride (bucumolol), a beta-adrenergic blocking agent, on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.
    Nakayama K; Oshima T; Koike H
    Jpn J Pharmacol; 1979 Dec; 29(6):935-45. PubMed ID: 44326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
    Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular studies of 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a new potent beta-adrenergic blocking agent.
    Yabuochi Y; Kinoshita D
    Jpn J Pharmacol; 1974 Dec; 24(6):853-61. PubMed ID: 4618580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic effects of bupuranolol against canine ventricular arrhythmias induced by halothane-adrenaline or two-stage coronary ligation.
    Hashimoto K; Tsukada T; Matsuda H; Nakagawa Y; Imai S
    J Cardiovasc Pharmacol; 1979; 1(2):205-17. PubMed ID: 94390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
    Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-arrhythmic action of nadolol, a beta-adrenergic receptor blocking agent.
    Evans DB; Peschka MT; Lee RJ; Laffan RJ
    Eur J Pharmacol; 1976 Jan; 35(1):17-27. PubMed ID: 3420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic effect of oxprenolol on halothane-epinephrine and coronary ligation induced ventricular arrhythmias in beagle dogs.
    Hashimoto K; Tsukada T; Matsuda H; Matsubara I; Imai S
    Jpn J Pharmacol; 1978 Aug; 28(4):535-44. PubMed ID: 32416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actions of a newly synthesized compound (711389-S) on various types of experimentally induced arrhythmias in mammalian species in situ.
    Kadowaki Y; Ohta T; Hotokebuchi N; Kimoto S; Haruna M; Nakao T; Ueda M; Nishi K
    Jpn J Pharmacol; 1988 Apr; 46(4):359-72. PubMed ID: 3404766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tiprenolol, practolol and propranolol on experimental ventricular tachyarrhythmias.
    Allen JD; Shanks RG
    Br J Pharmacol; 1974 Jun; 51(2):179-85. PubMed ID: 4155971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of alinidine on experimental cardiac arrhythmias.
    Harron DW; Allen JD; Wilson R; Shanks RG
    J Cardiovasc Pharmacol; 1982; 4(2):221-5. PubMed ID: 6175804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424.
    Kniffen FJ; Winokur S; Counsell RE; Lucchesi BR
    J Pharmacol Exp Ther; 1976 Feb; 196(2):420-32. PubMed ID: 3643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lignocaine and propranolol on experimental cardiac arrhythmias.
    Allen JD; Shanks RG; Zaidi SA
    Br J Pharmacol; 1971 May; 42(1):1-12. PubMed ID: 4103275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril hydrochloride(OPC-1085) on coronary circulation and myocardial metabolism].
    Takenaka F; Shintani S; Ishihara T; Higuchi M; Hiraki I
    Nihon Yakurigaku Zasshi; 1975 Mar; 71(2):221-30. PubMed ID: 1093960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the myocardial-selective alpha 1-adrenoceptor antagonist UK-52046 and atenolol, alone and in combination, on experimental cardiac arrhythmias in dogs.
    Uprichard AG; Harron DW; Wilson R; Shanks RG
    Br J Pharmacol; 1988 Dec; 95(4):1241-54. PubMed ID: 2905912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms underlying the antiarrhythmic properties of beta-adrenoceptor blockade against ischaemia-induced arrhythmias in acutely prepared rats.
    Paletta MJ; Abraham S; Beatch GN; Walker MJ
    Br J Pharmacol; 1989 Sep; 98(1):87-94. PubMed ID: 2572292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental anti-arrhythmic properties of melperone, a neuroleptic butyrophenone.
    Petersen EN
    Acta Pharmacol Toxicol (Copenh); 1978 May; 42(5):388-94. PubMed ID: 581034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents.
    Nakagawa K; Murakami N; Yoshizaki S; Tominaga M; Mori H
    J Med Chem; 1974 May; 17(5):529-33. PubMed ID: 4151493
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-arrhythmic effect of nadolol in experimental arrhythmias: comparison with propranolol and alprenolol.
    Nakashima M; Takiguchi Y; Oguro K; Sogabe K; Hashimoto H
    J Pharmacobiodyn; 1985 Jan; 8(1):1-10. PubMed ID: 4009395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic and cardiovascular effects of MP 115.
    Allen JD; Deering AH; Kelly JG; Shanks RG
    J Cardiovasc Pharmacol; 1983; 5(6):937-44. PubMed ID: 6196565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.